BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2469 related articles for article (PubMed ID: 18090226)

  • 1. Reduction of oxidative stress by a new low-molecular-weight antioxidant improves metabolic alterations in a nonobese mouse diabetes model.
    Novelli M; D'Aleo V; Lupi R; Paolini M; Soleti A; Marchetti P; Masiello P
    Pancreas; 2007 Nov; 35(4):e10-7. PubMed ID: 18090226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistent correction of hyperglycemia in streptozotocin-nicotinamide-induced diabetic mice by a non-conventional radical scavenger.
    Novelli M; Bonamassa B; Masini M; Funel N; Canistro D; De Tata V; Martano M; Soleti A; Campani D; Paolini M; Masiello P
    Naunyn Schmiedebergs Arch Pharmacol; 2010 Aug; 382(2):127-37. PubMed ID: 20512314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-diabetic properties of a non-conventional radical scavenger, as compared to pioglitazone and exendin-4, in streptozotocin-nicotinamide diabetic mice.
    Novelli M; Canistro D; Martano M; Funel N; Sapone A; Melega S; Masini M; De Tata V; Pippa A; Vecoli C; Campani D; De Siena R; Soleti A; Paolini M; Masiello P
    Eur J Pharmacol; 2014 Apr; 729():37-44. PubMed ID: 24530416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of antidiabetic drugs on glucose tolerance in streptozotocin-nicotinamide-induced mildly diabetic and streptozotocin-induced severely diabetic mice.
    Tahara A; Matsuyama-Yokono A; Nakano R; Someya Y; Shibasaki M
    Horm Metab Res; 2008 Dec; 40(12):880-6. PubMed ID: 18819058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-hyperglycemic, antioxidant and anti-inflammatory effects of VIP and a VPAC1 agonist on streptozotocin-induced diabetic mice.
    Yu R; Zhang H; Huang L; Liu X; Chen J
    Peptides; 2011 Feb; 32(2):216-22. PubMed ID: 21129425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective role of arjunolic acid in response to streptozotocin-induced type-I diabetes via the mitochondrial dependent and independent pathways.
    Manna P; Sinha M; Sil PC
    Toxicology; 2009 Mar; 257(1-2):53-63. PubMed ID: 19133311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-diabetic effects of electrolyzed reduced water in streptozotocin-induced and genetic diabetic mice.
    Kim MJ; Kim HK
    Life Sci; 2006 Nov; 79(24):2288-92. PubMed ID: 16945392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of masoprocol on carbohydrate and lipid metabolism in a rat model of Type II diabetes.
    Reed MJ; Meszaros K; Entes LJ; Claypool MD; Pinkett JG; Brignetti D; Luo J; Khandwala A; Reaven GM
    Diabetologia; 1999 Jan; 42(1):102-6. PubMed ID: 10027587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of insulin resistance with hyperglycemia in streptozotocin-diabetic pigs: effects of metformin at isoenergetic feeding in a type 2-like diabetic pig model.
    Koopmans SJ; Mroz Z; Dekker R; Corbijn H; Ackermans M; Sauerwein H
    Metabolism; 2006 Jul; 55(7):960-71. PubMed ID: 16784971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The anti-diabetic effect of anthocyanins in streptozotocin-induced diabetic rats through glucose transporter 4 regulation and prevention of insulin resistance and pancreatic apoptosis.
    Nizamutdinova IT; Jin YC; Chung JI; Shin SC; Lee SJ; Seo HG; Lee JH; Chang KC; Kim HJ
    Mol Nutr Food Res; 2009 Nov; 53(11):1419-29. PubMed ID: 19785000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-cell function and mass in type 2 diabetes.
    Larsen MO
    Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the combination of dipeptidyl peptidase-IV inhibitor ASP8497 and antidiabetic drugs in streptozotocin-nicotinamide-induced mildly diabetic mice.
    Tahara A; Matsuyama-Yokono A; Nakano R; Someya Y; Hayakawa M; Shibasaki M
    Eur J Pharmacol; 2009 Mar; 605(1-3):170-6. PubMed ID: 19171131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of cerebrocrast, a new long-acting compound on blood glucose and insulin levels in rats when administered before and after STZ-induced diabetes mellitus.
    Briede J; Stivrina M; Stoldere Dz; Vigante B; Duburs G
    Cell Biochem Funct; 2007; 25(6):673-80. PubMed ID: 16986170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the progression of type 2 diabetes in the C57BL/6J mouse model by an anti-diabetes herbal formula.
    Winters WD; Huo YS; Yao DL
    Phytother Res; 2003 Jun; 17(6):591-8. PubMed ID: 12820223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidiabetic effects of dipeptidyl peptidase-IV inhibitors and sulfonylureas in streptozotocin-nicotinamide-induced mildly diabetic mice.
    Matsuyama-Yokono A; Tahara A; Nakano R; Someya Y; Shiraki K; Hayakawa M; Shibasaki M
    Metabolism; 2009 Mar; 58(3):379-86. PubMed ID: 19217455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extract of Woodfordia fruticosa flowers ameliorates hyperglycemia, oxidative stress and improves β-cell function in streptozotocin-nicotinamide induced diabetic rats.
    Arya A; Al-Obaidi MM; Karim RB; Taha H; Khan AK; Shahid N; Sayem AS; Looi CY; Mustafa MR; Mohd MA; Ali HM
    J Ethnopharmacol; 2015 Dec; 175():229-40. PubMed ID: 26342523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of antidiabetic drugs in high-fat diet and streptozotocin-nicotinamide-induced type 2 diabetic mice.
    Tahara A; Matsuyama-Yokono A; Shibasaki M
    Eur J Pharmacol; 2011 Mar; 655(1-3):108-16. PubMed ID: 21266174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early oxidative stress in testis and epididymal sperm in streptozotocin-induced diabetic mice: its progression and genotoxic consequences.
    Shrilatha B; Muralidhara
    Reprod Toxicol; 2007 Jun; 23(4):578-87. PubMed ID: 17360155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of antioxidant supplementation on postprandial oxidative stress and endothelial dysfunction: a single-blind, 15-day clinical trial in patients with untreated type 2 diabetes, subjects with impaired glucose tolerance, and healthy controls.
    Neri S; Signorelli SS; Torrisi B; Pulvirenti D; Mauceri B; Abate G; Ignaccolo L; Bordonaro F; Cilio D; Calvagno S; Leotta C
    Clin Ther; 2005 Nov; 27(11):1764-73. PubMed ID: 16368447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methadone ameliorates multiple-low-dose streptozotocin-induced type 1 diabetes in mice.
    Amirshahrokhi K; Dehpour AR; Hadjati J; Sotoudeh M; Ghazi-Khansari M
    Toxicol Appl Pharmacol; 2008 Oct; 232(1):119-24. PubMed ID: 18671992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 124.